Tag: MEIP

Blue Horseshoe Stocks: DAL Recap & More

Delta Airlines, Inc. DAL

Each day this week, we’ve recapped some options trading success, along with generating a fresh idea. Our streak of success continued yesterday morning, as we brought yet another new set of options ideas to the table, and once again, were met with solid single-session success.

We targeted the DAL Weekly $49.50-51.50 Calls after a solid beat on earnings, and are pleased to report that every single contract contained within that selected range produced multi-bag gains, as it has been with our other earnings related ideas from both this and last week.

$49.50 Calls – Range: .42-1.85 – Max Gain: 340%
$50 Calls – Range: .23-1.40 – Max Gain: 509%
$50.50 Calls – Range: .13-1.00 – Max Gain: 669%
$51 Calls – Range: .08-.67 – Max Gain: 738%
$51.50 Calls – Range: .03-.40 – Max Gain: 1233%
_________

Fresh Idea :
Wells Fargo & Co. WFC $56.50-54.50 Puts

Genesis Healthcare, Inc. GEN – Bottom Watch

We would like to place GEN on bottom watch this morning, after taking notice of the chart setup on our routine scan this morning.

As you can see from the included snapshot, we have a number of factors contributing to the stock’s attractive bottom setup. The stock has been falling sharply all week, cruising down toward its 200DMA at an alarming rate. Additionally, we have a MACD which is exhibiting unsustainable downward divergence, and an RSI indicating the stock has just entered extremely oversold territory.

This is exactly the sort of setup we look for in potential bottom bounce plays, and we’re going to slot GEN for observation in coming sessions to be ready for that eventuality.

Extended Watchlist:
GLMD, BIOC, MEIP, CPRX, ABIL, ADXS, GOGO BLIN,

Blue Horseshoe Stocks: SODE New Highs & More

Social Detention, Inc. SODE

It was just yesterday morning that we commenting on our coverage of SODE, the subject of a special report we did two weeks ago, at which time the stock was trading for as little as .10.

We mentioned the 53% gain it had already made leading into yesterday’s session,
and that we wanted to watch for it to establish higher highs and higher lows, continuing its current uptrend.

We didn’t have to wait for new highs to come rolling in- SODE once again pushed its upper limits and attained a high of .27, marking an overall two-week upswing of 170% It traded with volatility as well, providing not one but four separate intraday swings, as you can see on the intraday chart below.

In sequential order, those swings came from .145-.26 (+79%), .19-.26 (+37%), .19-.27 (+42%) and from .20-.26 (+30%), for cumulative gains of 188% on the day.

Signet Jewelers Ltd. SIG – Options Idea

With SIG posting a solid beat on earnings this morning, we’re going to want to be standing ready with a set of options ideas to take advantage of what is some intense premarket acivity, with the stock in the process of filling a gap on the chart from late March.

Based on the stocks early hours performance, we’re going to slate the SIG Weekly $47.50-50 Calls for observation as we head through this midweek.

Extended Watchlist:
ABEO, AXON, MEIP, NLST, DOVA, FATE, SNES

Blue Horseshoe Stocks: CYBR, MCP, MEIP & More

CyberArk Software, Ltd. CYBR

Our first experiences with CYBR were good ones, when we successfully called a couple of potentially lucrative options trades around the middle of last month. It was in our report from February 13ththat we targeted CYBR $50 and $55 Calls, and that day we saw moves in those contracts of 72% and 165% respectively.
–
We flagged CYBR once again yesterday, which had previously been under several weeks of consolidation, yet was gapping up in the premarket. The stock did well in reversing its path, trading in a range from 50.79-55.03, and holding the majority of those gains into the close.

Our current options idea is going to be the 04/17 $50 Calls (Closed at 6.60 yesterday). Should CYBR reach its way back to the $60-level anytime in the next few weeks, the gains we see in those contracts will be quite substantial.

Molycorp, Inc. MCP

MCP appeared in yesterday’s extended watchlist and demonstrated a reversal of its own. We’re going to place MCP on more intensive watch as the week progresses, as it has the markings of a potential bottom play.

We’ve illustrated some of the key characteristics of the chart below, which appears to be gearing up for what could be a big swing. The stock ran well over a dollar at the beginning of last month, so the potential for rapid gains has certainly been demonstrated.

MEI Pharma, Inc. MEIP

We’ve also got an eye on MEIP after the stock was crushed down to a 52-week low yesterday, following the company’s announcement of the failure of its cancer drug in middle-stage testing.

A single-session depreciation on the order of 70% is the hallmark of one heck of a knee-jerk reaction, and the stock appears to be gapping up slightly this morning, so we’ll be on the lookout for a recovery in MEIP shares in coming days.

Extended Watchlist:
IMGN, ATOS ISR, HEB, GEVO, NEPT